| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.8M | -80.1% |
| Cost of Revenue | $4.2M | -23.6% |
| Gross Profit | $2.6M | -90.9% |
| R&D Expense | $23.0M | +31.7% |
| SG&A Expense | $14.3M | +0.1% |
| Operating Income | -$42.7M | -58.3% |
| Pre-tax Income | -$38.1M | -102.2% |
| Income Tax | -$2.8M | +39.7% |
| Net Income | -$35.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | -35.1% |
| Short-term Investments | $43.6M | -25.1% |
| Accounts Receivable | $304K | -91.2% |
| Inventory | $1.7M | -68.7% |
| Current Assets | $62.1M | -33.0% |
| Total Assets | $95.3M | -22.6% |
| Current Liabilities | $5.7M | +48.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.1M | -436.2% |
| Capital Expenditures | $1.4M | -4.4% |
| Investing Cash Flow | $15.4M | +126.5% |
| Financing Cash Flow | -$1.4M | +90.3% |
| Free Cash Flow | -$23.4M | -556.1% |
| -148.2% |
| EPS (Basic) | -$1.20 | -166.7% |
| EPS (Diluted) | -$1.20 | -166.7% |
| Total Liabilities |
| $9.3M |
| +8.6% |
| Stockholders' Equity | $86.0M | -24.9% |